The results showed that using FSCN1 positivity as a predictor for ICC had a sensitivity, specificity, PPV, and NPV of 92.3%, 86.1%, 61.5%, and 97.9%, respectively. This evidence concerns the gene FSCN1 and intrahepatic cholangiocarcinoma.